Detalhe da pesquisa
1.
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies.
Neuropathol Appl Neurobiol;
47(6): 711-723, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33999469
2.
Evaluation of Exon Skipping and Dystrophin Restoration in In Vitro Models of Duchenne Muscular Dystrophy.
Methods Mol Biol;
2434: 217-233, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35213020
3.
miR-106b is a novel target to promote muscle regeneration and restore satellite stem cell function in injured Duchenne dystrophic muscle.
Mol Ther Nucleic Acids;
29: 769-786, 2022 Sep 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36159592
4.
Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening.
Sci Rep;
11(1): 18188, 2021 09 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34521928
5.
An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I.
Genes (Basel);
11(9)2020 09 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32971903
6.
MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro.
Fluids Barriers CNS;
13(1): 8, 2016 May 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27246706
7.
Comments on «Hipercarotinemia after bariatric surgery¼. / Comentarios sobre «Hipercarotinemia tras cirugía bariátrica¼.
Endocrinol Nutr;
63(7): 374-5, 2016.
Artigo
em Inglês, Espanhol
| MEDLINE
| ID: mdl-27346598